Overview

Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women

Status:
Recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics, efficacy and safety of TAF in HBV-infected pregnant women.
Phase:
Phase 4
Details
Lead Sponsor:
First People's Hospital of Hangzhou
Treatments:
Tenofovir